nr |
titel |
auteur |
tijdschrift |
jaar |
jaarg. |
afl. |
pagina('s) |
type |
1 |
A guidance for renal biomarker lead optimization and use in translational pharmacodynamics
|
Ozer, Josef S. |
|
2010 |
15 |
3-4 |
p. 142-147 6 p. |
artikel |
2 |
Biologics: a new approach needed?
|
Foster, Keith A. |
|
2010 |
15 |
3-4 |
p. 81-83 3 p. |
artikel |
3 |
Can molecular biomarker-based patient selection in Phase I trials accelerate anticancer drug development?
|
Carden, Craig P. |
|
2010 |
15 |
3-4 |
p. 88-97 10 p. |
artikel |
4 |
Circulating tumour-derived predictive biomarkers in oncology
|
Hodgson, Darren R. |
|
2010 |
15 |
3-4 |
p. 98-101 4 p. |
artikel |
5 |
Contents page 2
|
|
|
2010 |
15 |
3-4 |
p. iii- 1 p. |
artikel |
6 |
Contents page 1
|
|
|
2010 |
15 |
3-4 |
p. i- 1 p. |
artikel |
7 |
From biomarker strategies to biomarker activities and back
|
van Gool, Alain J. |
|
2010 |
15 |
3-4 |
p. 121-126 6 p. |
artikel |
8 |
Isotopic biomarker discovery and application in translational medicine
|
Bayele, Henry K. |
|
2010 |
15 |
3-4 |
p. 127-136 10 p. |
artikel |
9 |
Progress towards personalized medicine
|
Bates, Stewart |
|
2010 |
15 |
3-4 |
p. 115-120 6 p. |
artikel |
10 |
Recent advances in molecular imaging biomarkers in cancer: application of bench to bedside technologies
|
van der Meel, Roy |
|
2010 |
15 |
3-4 |
p. 102-114 13 p. |
artikel |
11 |
The importance of aryl C–Cl⋯π interaction in ligand–protein binding
|
Yeung, Kap-Sun |
|
2010 |
15 |
3-4 |
p. 158- 1 p. |
artikel |
12 |
The quest for biomarkers in tuberculosis
|
Parida, Shreemanta K. |
|
2010 |
15 |
3-4 |
p. 148-157 10 p. |
artikel |
13 |
The rise of micropharma
|
Barden, Christopher J. |
|
2010 |
15 |
3-4 |
p. 84-87 4 p. |
artikel |
14 |
Use of biomarkers in the discovery of novel anti-schizophrenia drugs
|
Mikkelsen, Jens D. |
|
2010 |
15 |
3-4 |
p. 137-141 5 p. |
artikel |